Literature DB >> 10859365

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.

P J Muchowski1, G Schaffar, A Sittler, E E Wanker, M K Hayer-Hartl, F U Hartl.   

Abstract

The deposition of protein aggregates in neurons is a hallmark of neurodegenerative diseases caused by polyglutamine (polyQ) proteins. We analyzed the effects of the heat shock protein (Hsp) 70 chaperone system on the aggregation of fragments of huntingtin (htt) with expanded polyQ tracts. In vitro, Hsp70 and its cochaperone Hsp40 suppressed the assembly of htt into detergent-insoluble amyloid-like fibrils in an ATP-dependent manner and caused the formation of amorphous, detergent-soluble aggregates. The chaperones were most active in preventing fibrillization when added during the lag phase of the polymerization reaction. Similarly, coexpression of Hsp70 or Hsp40 with htt in yeast inhibited the formation of large, detergent-insoluble polyQ aggregates, resulting in the accumulation of detergent-soluble inclusions. Thus, the recently established potency of Hsp70 and Hsp40 to repress polyQ-induced neurodegeneration may be based on the ability of these chaperones to shield toxic forms of polyQ proteins and to direct them into nontoxic aggregates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859365      PMCID: PMC16632          DOI: 10.1073/pnas.140202897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.

Authors:  E E Wanker; E Scherzinger; V Heiser; A Sittler; H Eickhoff; H Lehrach
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  Molecular basis of the neurodegenerative disorders.

Authors:  J B Martin
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

3.  Compartmentation of protein folding in vivo: sequestration of non-native polypeptide by the chaperonin-GimC system.

Authors:  K Siegers; T Waldmann; M R Leroux; K Grein; A Shevchenko; E Schiebel; F U Hartl
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

Review 4.  Polyglutamine diseases: protein cleavage and aggregation.

Authors:  H Y Zoghbi; H T Orr
Journal:  Curr Opin Neurobiol       Date:  1999-10       Impact factor: 6.627

5.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.

Authors:  E Scherzinger; A Sittler; K Schweiger; V Heiser; R Lurz; R Hasenbank; G P Bates; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 6.  Glutamine repeats and neurodegenerative diseases: molecular aspects.

Authors:  M F Perutz
Journal:  Trends Biochem Sci       Date:  1999-02       Impact factor: 13.807

7.  A zinc finger-like domain of the molecular chaperone DnaJ is involved in binding to denatured protein substrates.

Authors:  A Szabo; R Korszun; F U Hartl; J Flanagan
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

8.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias.

Authors:  Y Trottier; Y Lutz; G Stevanin; G Imbert; D Devys; G Cancel; F Saudou; C Weber; G David; L Tora
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

9.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

Authors:  J Nasir; S B Floresco; J R O'Kusky; V M Diewert; J M Richman; J Zeisler; A Borowski; J D Marth; A G Phillips; M R Hayden
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

Review 10.  Roles of molecular chaperones in protein degradation.

Authors:  S A Hayes; J F Dice
Journal:  J Cell Biol       Date:  1996-02       Impact factor: 10.539

View more
  220 in total

Review 1.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Association of plasma antibodies against the inducible Hsp70 with hypertension and harsh working conditions.

Authors:  T Wu; J Ma; S Chen; Y Sun; C Xiao; Y Gao; R Wang; J Poudrier; M Dargis; R W Currie; R M Tanguay
Journal:  Cell Stress Chaperones       Date:  2001-10       Impact factor: 3.667

3.  Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.

Authors:  Monica Beam; M Catarina Silva; Richard I Morimoto
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

4.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 5.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

Review 6.  Mechanisms for regulation of Hsp70 function by Hsp40.

Authors:  Chun-Yang Fan; Soojin Lee; Douglas M Cyr
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

7.  Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration.

Authors:  J Lille Tidwell; Lucien J Houenou; Michael Tytell
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

8.  Serum and lymphocyte levels of heat shock protein 70 in aging: a study in the normal Chinese population.

Authors:  Xingfang Jin; Ruibo Wang; Chengfeng Xiao; Longxian Cheng; Feng Wang; Li Yang; Taoyi Feng; Ming Chen; Sheng Chen; Xiaoye Fu; Jie Deng; Ru Wang; Fangfang Tang; Qingyi Wei; Robert M Tanguay; Tangchun Wu
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

9.  Complete suppression of Htt fibrilization and disaggregation of Htt fibrils by a trimeric chaperone complex.

Authors:  Annika Scior; Alexander Buntru; Kristin Arnsburg; Anne Ast; Manuel Iburg; Katrin Juenemann; Maria Lucia Pigazzini; Barbara Mlody; Dmytro Puchkov; Josef Priller; Erich E Wanker; Alessandro Prigione; Janine Kirstein
Journal:  EMBO J       Date:  2017-12-06       Impact factor: 11.598

Review 10.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.